Advertisement

Topics

Latest "England Anti Vivisection Society" News Stories

12:36 EST 16th December 2018 | BioPortfolio

Here are the most relevant search results for "England Anti Vivisection Society" found in our extensive news archives from over 250 global news sources.

More Information about England Anti Vivisection Society on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about England Anti Vivisection Society for you to read. Along with our medical data and news we also list England Anti Vivisection Society Clinical Trials, which are updated daily. BioPortfolio also has a large database of England Anti Vivisection Society Companies for you to search.

Showing "England Anti Vivisection Society" News Articles 1–25 of 7,500+

Relevant

RPS ambassador scheme to champion the Society across England

The Royal Pharmaceutical Society in England has appointed ten ambassadors to champion the benefits of being a member.


Eisai: Long-Term Cardiovascular Outcomes Data for Anti-Obesity Agent BELVIQ

Presented at The European Society of Cardiology and Published in the New England Journal of MedicineTOKYO, Aug 28, 2018 - (JCN Newswire) - The average change in weight from baseline was -4.2 kg wit...

Parents should ignore anti-vaccine "social media fake news", according to England's medical chief

England’s Chief Medical Officer Dame Sally Davies has said that the MMR vaccine is “a safe vaccination” as she encouraged parents to vaccinate their children and ignore anti-vaccine myths and “social media fake news”. The call has come on the 30th anniversary of the introduction of the MMR vaccine into the UK. read more


‘Social media fake news’ to blame for low MMR vaccine take up, says England’s top doctor – Telegraph.co.uk

Telegraph.co.uk'Social media fake news' to blame for low MMR vaccine take up, says England's top doctorTelegraph.co.ukThe spreading of "social media fake news" is to blame for the low rate of children getting their MMR vaccine, England's top doctor has said. Professor Dame Sally Davies said parents who believe the lies circulated online by anti-vaccine campaigners ...'Don't be taken in by anti-vac...

MS Society launches petition against NICE’s rejection of Ocrevus

The MS Society has launched a petition imploring the National Institute for Health and Care Excellence, NHS England and Roche to come to an agreement on NHS availability of Ocrevus for primary progressive multiple sclerosis (PPMS).

Study reveals increasing life expectancy gap between richest and poorest communities in England

The gap between the life expectancy of the richest and poorest sectors of society in England is increasing, according to new research from Imperial College London.

The Life Expectancy Of England’s Poorest Women Has Declined, Worrying New Research Says – Bustle

BustleThe Life Expectancy Of England's Poorest Women Has Declined, Worrying New Research SaysBustleAn alarming new study has revealed that the life expectancy of England's poorest women has declined since 2011, while the disparity between the life expectancies of the most affluent and the most deprived areas of society is widening. According to ...Poorest dying nearly 10 years younger than the ric...

Parents should ignore anti-vaccine "social media fake news", according to England's medical chief http://bit.ly/2PwhlTc  #vaccines #FakeNewspic.twitter.com/nrKwlaHwh7

Parents should ignore anti-vaccine "social media fake news", according to England's medical chief http://bit.ly/2PwhlTc  #vaccines #FakeNews pic.twitter.com/nrKwlaHwh7

Parents should ignore anti-vaccine "social media fake news", according to England's medical chief http://bit.ly/2PwhlTc  #vaccines #FakeNews #antivaccines

Parents should ignore anti-vaccine "social media fake news", according to England's medical chief http://bit.ly/2PwhlTc  #vaccines #FakeNews #antivaccines

Ravi Sharma appointed RPS director for England

Ravi Sharma has been appointed as the Royal Pharmaceutical Society’s director of England.

NHS England appoints national clinical advisor for primary care

NHS England has appointed a specialist GP to encourage the spread of innovations that integrate health and social care throughout England.

Over 400,000 sexually transmitted infections reported in England in 2017, PHE report reveals

The number of confirmed cases of gonorrhoea and syphilis in England in 2017 rose by 22% and 20%, respectively, according to data released by Public Health England.

BPS announces 2019 Society Fellows

(Biophysical Society) The Biophysical Society (BPS) announced its 2019 Society Fellows. This designation honors the Society's distinguished members who have demonstrated excellence in science, contributed to the expansion of the field of biophysics, and supported the Biophysical Society throughout their careers.

Anti-CGRP Monoclonal Antibodies for Migraine Prevention

Dr Deborah Friedman reviews the new anti-CGRP monoclonal antibodies for migraine prevention. American Headache Society and Medscape

Repurposing selective PDE5 inhibitors as anti-cancer agents

Dr Pantziarka speaks with ecancer at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting about a recent paper, published in ecancermedicalscience, looking at repurposing selective PDE5 inhibitors as anti-cancer agents.

GP trainees recruited in England surpass target

The number of doctors entering GP training in England this year has surpassed the target set by Health Education England (HEE) by more than 200.HEE said that 3473 trainees were starting their GP...

England sees “steep rise” in measles cases

Public Health England is urging the public to ensure they have had two doses of MMR vaccine after outbreaks of measles are confirmed across England.

S100B and LDH as early prognostic markers for response and overall survival in melanoma patients treated with anti-PD-1 or combined anti-PD-1 plus anti-CTLA-4 antibodies

NHS England appoves Gilead's CAR T therapy Yescarta

Gilead’s CAR T therapy Yescarta is set to be made available on the NHS in England for adults with aggressive non-Hodgkin lymphoma, it was announced today. Although NICE rejected the £300,000 per patient treatment in August of this year, NHS England has come to a confidential agreement with Yescarta manufacturer Gilead Sciences. Thus an estimated 200 patients a year could benefit from the person...

UK health improving but challenges of an ageing population remain, says PHE report

A new report from Public Health England (PHE) has illuminated the primary health concerns in UK society today, revealing the extent of rising demands for healthcare as the population continues to age. The [Health Profile for England] report shows that in some areas, public health in the UK is improving. Life expectancy has gone up, with men living for 79.6 years on average, while this figure stand...

New Hampshire Governor Signs Transgender Anti-Discrimination, Gay Conversion Therapy Ban Bills Into Law

New Hampshire had been the only New England state without protections for transgender people. It joins 19 other states in doing so.

Government should make health checks available through high street pharmacies, says RPS

The Royal Pharmaceutical Society says an overhauled national contract for community pharmacy in England could increase the profession’s influence in shaping the NHS of the future.

Medical News Today: What can you eat on an anti-inflammatory diet?

People with rheumatoid arthritis (RA) may wish to follow an anti-inflammatory diet to reduce the painful inflammation that this condition causes. There are many healthful anti-inflammatory recipes available for breakfast, lunch, dinner, and snacks in between. Learn more about following an anti-inflammatory diet here.

The World Cup: When England Plays, This Is What Happens To Violence

After England beat Sweden 2-0 in the quarterfinals of the World Cup, English fans trashed an IKEA. A study found what happens to domestic violence when England plays in the World Cup.

BeiGene to Present Clinical Data on Anti-PD-1 Antibody Tislelizumab at the European Society for Medical Oncology Immuno-Oncology Congress

CAMBRIDGE, Mass., and BEIJING, China, Dec. 10, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly-targeted and immuno-oncology drugs for the treatment of cancer, today announced it will present data on its investigational anti-PD-1 antibody tislelizumab at the European ...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks